Investors

3rd Annual Immuno-Oncology BD&L and Investment Forum

Jun 2, 2017 at 1:10 PM EDT

June 2, 2017, Track B - 1:10pm
Alexey Eliseev, PhD, Chief Business Officer, RXi Pharmaceuticals
Presentation -Targeting Immune Checkpoints in Adoptive Cell Transfer Using Self-Delivering RNAi (sd-rxRNA®) Technology

Supporting Materials

Location

Hyatt Chicago Magnificent Mile Hotel, Illinois

Investors